Main > ENDOCRINOLOGY > Osteoporosis > Prevention > Bazedoxifene > Co.: USA. P. (Reg. Review) > Patent>Abstract

---

This invention relates to extended dosing regimens for the selective estrogen receptor modulator bazedoxefine (1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol).


Patent>Abstract's products
This section has no products